期刊文献+

氯胺酮致小鼠产生类精神分裂症与NRG1、ErbB4 mRNA表达的相关性 被引量:1

The Correlation between Ketamine-induced Schizophrenia-like Signs in Mice and the Expressions of NRG1,ErbB4 mRNA
下载PDF
导出
摘要 目的探讨氯胺酮连续给药致小鼠产生的类似精神分裂症症状,与精神分裂症易感基因神经调节蛋白1(neuregulin-1,NRG1)及其受体ErbB4 mRNA表达的相关性,为研究精神分裂症的可能发病机制提供参考依据。方法50只雄性昆明种小鼠,随机分为生理盐水组、氯胺酮小剂量(25 mg/kg)、中剂量(50 mg/kg)、大剂量(100 mg/kg)组和氯氮平治疗组,腹腔注射给药,1次/d,连续7 d。氯氮平组在连续腹腔注射7d氯胺酮(1次/d,每次100mg/kg)后,再用氯氮平灌胃7d(1次/d,每次20mg/kg)。HE染色观察海马神经元的变化;采用逆转录-聚合酶链反应(RT-PCR)检测海马中NRG1及ErbB4 mRNA的表达。结果注射7d氯胺酮后,大剂量组海马区NRG1及ErbB4 mRNA的表达显著减少。结论氯胺酮诱导小鼠产生类似精神分裂症的症状,可能与海马区NRG1及ErbB4 mRNA的表达减少相关联。 Objective To explore the correlation between signs similar to schizophrenia in mice after ketamine administration and the expressions of NRG1 and ErbB4 mRNA in order to explain the possible pathogenesis of schizophrenia. Methods Fifty KM mice were randomly divided into 5 groups which were administered in- traperitoneally with saline, elozapine and different dosages ketamine. The ketamine groups were administered intraperitoneally with low dosage(25 mg/kg), middle dosage (50 mg/kg) and high dosage (100 mg/kg) one time every day for 7 days. After administration of 100 mg/kg ketamine for 7 days, the elozapine group was introgastrically administered 20 mg/kg with clozapine one time every day for 7 days. The pathological changes of hippocampus neurons were observed by HE stain. The expressions of the NRG1 and ErbB4 mRNA in hippocampus were detected by reverse transcriptase polymerase chain reaction (RT-PCR). Results In the group with high dosage of ketamine, the levels of NRG1 and ErbB4 mRNA were significantly lower than that of the group with saline. Conclusion Ketamine may induce signs similar to schizophrenia in KM mice. The mechanism may be involved in the reduction of NRG1 and ErbB4 mRNA expression.
出处 《法医学杂志》 CAS CSCD 2009年第5期348-351,358,共5页 Journal of Forensic Medicine
基金 香港保健协会资助项目(20060909-9HK)
关键词 司法精神病学 精神分裂症 氯胺酮 NRG1 ERBB4 小鼠 forensic psychiatry schizophrenia ketamine NRG1 ErbB4 mice
  • 相关文献

参考文献14

  • 1Morgan C J, Rossell SL, Pepper F, et al. Semantic priming after ketamine acutely in heahhy volunteers and following chronic self-administration in substance users[J]. Biol Psychiatry, 2006,59 (3) : 265-272.
  • 2Corlett PR, Honey GD, Fletcher PC. From prediction error to psychosis: ketamine as a pharmacological model of delusions [J]. J Psychopharmaeol, 2007,21 (3) : 238-252.
  • 3刘伟丽,卞士中,顾振纶,蒋小岗,郭次仪,赵彦伯.氯胺酮致小鼠产生类精神分裂症的行为改变[J].法医学杂志,2009,25(3):172-175. 被引量:4
  • 4Low SJ, Roland CL. Review of NMDA antagonist-induced neurotoxicity and implications for clinical development[J]. Int J Clin Pharmacol Ther,2004,42(1):1-14.
  • 5Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortieal neurons by phencyclidine and related drugs[J]. Science, 1989,244 (4910) : 1360-1362.
  • 6Corvin AP, Morris DW, McGhee K, et al. Confirmation and refinement of an ‘at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus[J]. Mol Psychiatry, 2004,9 (2) : 208-213.
  • 7Buonanno A, Fischbach GD. Neuregulin and ErbB receptor signaling pathways in the nervous system[J]. Curr Opin Neurobiol, 2001,11 (3) :287-296.
  • 8Arnold SE, Talbot K, Hahn CG. Neurodevelopment, neuroplasticity, and new genes for schizophrenia[J]. Prog Brain Res, 2005,147:319-345.
  • 9Norton N, Moskvina V, Morris DW, et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia[J]. Am J Med Genet B Neuropsychiatr Genet,2006,141B(1): 96-101.
  • 10Silberberg G, Darvasi A, Pinkas-Kramarski R, et al. The involvement of ErbB4 with schizophrenia: association and expression studies[J]. Am J Med Genet B Neuropsychiatr Genet,2006,141B(2) : 142-148.

二级参考文献26

  • 1李晓白,方贻儒,王祖承,井上猛,小山司.精神分裂症动物模型研究进展[J].上海精神医学,2004,16(3):184-186. 被引量:5
  • 2永红.氯胺酮麻醉的副作用70例分析[J].西藏医药,2007,28(1):19-20. 被引量:3
  • 3Tso MM,Blatchford KL,Callado LF,et al.Stereoselective effects of ketamine on dopamine,serotonin and noradrenaline release and uptake in rat brain slices[J].Neurochem Int,2004,44(1):1-7.
  • 4Behrens MM,Ali SS,Dugan LL.Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia[J].J Neurosci,2008,28(51):13957-13966.
  • 5Corlett PR,Honey GD,Fletcher PC.From prediction error to psychosis:ketamine as a pharmacological model of delusions[J].J Psychopharmacol,2007,21 (3):238-252.
  • 6Zuo DY,Wu YL,Yao WX,et al.Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of freemoving mice,as determined by in vivo microdialysis[J].Pharmacol Biochem Behav,2007,86 (1):1-7.
  • 7Huang NK,Wan FJ,Tseng CJ,et al.Amphetamine induces hydroxyl radical formation in the striatum of rats[J].Life Sci,1997,61 (22):2219-2229.
  • 8Donnan GA,Willis GL,Kaczmarczyk SJ,et al.Motor function in the l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-treated mouse[J].J Neurol Sei,1987,77(2-3):185-191.
  • 9Morgan C J,Rossell SL,Pepper F,et al.Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in subsance users[J].Biol Psychiatry,2006,59 (3):265-272.
  • 10Lim DK.Ketamine associated psychedelic effects and dependence[J].Singapore Med J,2003,44 (1):31-34.

共引文献5

同被引文献27

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部